Phosphatidylserine (PS) exposure on the cell surface is an early marker of apoptosis. To select PS binding peptides as vectors of contrast agents to image apoptosis, a phage library has been exposed to perfused mouse livers. Phages not retained on control livers during the first perfusions were used for selections on apoptotic livers in a second series of perfusions. Four selected phages were further evaluated for binding to PS-coated enzyme-linked immunosorbent assay (ELISA) plates. They presented an apparent affinity constant (Ka app) for PS ranging from 6.08 × 1010 M to 1.62 × 1011M. These phages did not bind to phosphatidylcholine, and competition with annexin V confirmed their specific interaction with PS. The phage with the highest affinity-bound PS in ELISA with a Ka app = (1.6 ± 0.2) × 1011M. It carried the TLVSSL peptide that was synthesized. Specific competition with annexin V and with the synthetic peptide was performed and confirms the specificity of the interaction. (Journal of Biomolecular Screening 2006:537-545)
Savill J, Fadok V: Corpse clearance defines the meaning of cell death. Nature2000;407:784-788.
2.
Maderna P, Godson C: Phagocytosis of apoptotic cells and the resolution of inflammation. Biochim Biophys Acta2003;1639:141-151.
3.
Meier P, Finch A, Evan G: Apoptosis in development. Nature2000;407:796-801.
4.
Zhang J, Xu M: Apoptotic DNA fragmentation and tissue homeostasis. Trends Cell Biol2002;12:84-89.
5.
Rich T, Allen RL, Wyllie AH: Defying death after DNA damage. Nature2000;407:777-783.
6.
Ferri KF, Kroemer G: Organelle-specific initiation of cell death pathways. Nat Cell Biol2001;3:E255-E263.
7.
Oakes SA, Opferman JT, Pozzan T, Korsmeyer SJ, Scorrano L: Regulation of endoplasmic reticulum Ca2+ dynamics by proapoptotic BCL-2 family members. Biochem Pharmacol2003;66:1335-1340.
8.
Thatte U, Dahanukar S: Apoptosis: clinical relevance and pharmacological manipulation. Drugs1997;54:511-532.
9.
Hengartner MO: The biochemistry of apoptosis. Nature2000;407:770-776.
10.
Gross A: BCL-2 proteins: regulators of the mitochondrial apoptotic program. IUBMB Life2001;52:231-236.
11.
Zimmermann KC, Bonzon C, Green DR: The machinery of programmed cell death. Pharmacol Ther2001;92:57-70.
12.
Offer H, Erez N, Zurer I, et al: The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA. Carcinogenesis2002;23:1025-1032.
13.
Bernstein C, Bernstein H, Payne CM, Garewal H: DNA repair/ pro-apoptotic dual-role proteins in five major DNA repair pathways: failsafe protection against carcinogenesis. Mutat Res2002;511:145-178.
14.
Honig LS, Rosenberg RN: Apoptosis and neurologic disease. Am J Med2000;108:317-330.
15.
Friedlander RM: Apoptosis and caspases in neurodegenerative diseases. N Engl J Med2003;348:1365-1375.
16.
Lev N, Melamed E, Offen D: Apoptosis and Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry2003;27:245-250.
17.
Festoff BW: Amyotrophic lateral sclerosis: current and future treatment strategies. Drugs1996;51:28-44.
18.
Krammer PH: CD95's deadly mission in the immune system. Nature2000;407:789-795.
19.
Lorenz HM, Herrmann M, Winkler T, Gaipl U, Kalden JR: Role of apoptosis in autoimmunity. Apoptosis2000;5:443-449.
20.
Martinez OM, Krams SM: Involvement of Fas-Fas ligand interactions in graft rejection. Int Rev Immunol1999;18:527-546.
21.
Kohli V, Selzner M, Madden JF, Bentley RC, Clavien PA: Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation1999;67:1099-1105.
22.
Gujral JS, Bucci TJ, Farhood A, Jaeschke H: Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis?Hepatology2001;33:397-405.
23.
Schlegel RA, Williamson P: Phosphatidylserine, a death knell. Cell Death Differ2001;8:551-563.
24.
Kagan VE, Fabisiak JP, Shvedova AA, et al: Oxidative signaling pathway for externalization of plasma membrane phosphatidylserine during apoptosis. FEBS Lett2000;477:1-7.
25.
Van den Eijnde SM, Boshart L, Reutelingsperger C, De Zeeuw CI, Vermeij-Keers C: Phosphatidylserine plasma membrane asymmetry in vivo: a pancellular phenomenon which alters during apoptosis. Cell Death Differ1997;4:311-316.
26.
van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP: Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry1998;31:1-9.
27.
Blankenberg FG, Katsikis PD, Tait JF, et al: Imaging of apoptosis (programmed cell death) with 99mTc annexin V. J Nucl Med1999;40:184-191.
28.
Blankenberg F, Narula J, Strauss HW: In vivo detection of apoptotic cell death: a necessary measurement for evaluating therapy for myocarditis, ischemia, and heart failure. J Nucl Cardiol1999;6:531-539.
29.
Smith GP, Petrenko VA: Phage display. Chem Rev1997;97:391-410.
30.
Burritt JB, Bond CW, Doss KW, Jesaitis AJ: Filamentous phage display of oligopeptide libraries. Anal Biochem1996;238:1-13.
31.
Koivunen E, Arap W, Rajotte D, Lahdenranta J, Pasqualini R: Identification of receptor ligands with phage display peptide libraries. J Nucl Med1999;40:883-888.
32.
Sidhu SS, Lowman HB, Cunningham BC, Wells JA: Phage display for selection of novel binding peptides. Methods Enzymol2000;328:333-363.
33.
Zhang J, Spring H, Schwab M: Neuroblastoma tumor cell-binding peptides identified through random peptide phage display. Cancer Lett2001;171:153-164.
34.
Samoylova TI, Ahmed BY, Vodyanoy V, et al: Targeting peptides for microglia identified via phage display. J Neuroimmunol2002;127:13-21.
35.
Rajotte D, Arap W, Hagedorn M, Koivunen E, Pasqualini R, Ruoslahti E: Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest1998;102:430-437.
36.
Pasqualini R, Koivunen E, Ruoslahti E: Alpha V integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol1997;15:542-546.
37.
Odermatt A, Audige A, Frick C, et al: Identification of receptor ligands by screening phage-display peptide libraries ex vivo on microdissected kidney tubules. J Am Soc Nephrol2001;12:308-316.
38.
Scott JK, Smith GP: Searching for peptide ligands with an epitope library. Science1990;249:386-390.
39.
Colet JM, Pierart C, Seghi F, Gabric I, Muller RN: Intravascular and intracellular hepatic relaxivities of superparamagnetic particles: an isolated and perfused organ pharmacokinetics study. J Magn Reson1998; 134:199-205.
40.
Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al: Lethal effect of the anti-Fas antibody in mice. Nature1993;364:806-809.
41.
Nonclercq D, Reverse D, Toubeau G, et al: In situ demonstration of germinal cell apoptosis during diethylstilbestrol-induced testis regression in adult male Syrian hamsters. Biol Reprod1996;55:1368-1376.
42.
Nonclercq D, Zanen J, Toubeau G, Laurent G, Heuson-Stiennon JA: Apoptosis and cell proliferation in the seminal vesicles and coagulating glands of male Syrian hamsters exposed to diethylstilboestrol (DES). Reprod Fertil Dev1999;11:111-122.
43.
Roe BA, Crabtree JS, Khan AS: DNA Isolation and Sequencing. New York: John Wiley, 1989.
44.
Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM: Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem1990;265:4923-4928.
